Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis

Effusion Joint Clinical Trial

Official title:

Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03327584
• Other study ID #: 24623
• Status: Completed
• Phase: N/A
• Start date: January 1, 2017
• Est. completion date: December 31, 2019

Study information

• Verified date: January 2020
• Source: Temple University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Arthrocentesis is the removal of synovial fluid for analysis of pathologic processes. Small & medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger, ankle and toe. Ultrasound (US) and landmark (LM) small & medium joint arthrocentesis are both performed within the clinical setting. Both techniques are considered standard of care. Selection of which technique to use is dependent upon the physician's preference. There is currently limited data comparing the two methods. The investigators hope to determine if one modality is more effective in terms of success rate, number of attempts, and time to complete the procedure.

Description:

Patients presenting to the Emergency Department who are 18 years old or older, who do not belong to a vulnerable group, requiring small or medium joint arthrocentesis will be included in this trial. The investigators will randomize each patient into LM vs US. Data collected will include number of attempts to tap the joint, success rate, and time for procedure to be completed. The arthrocentesis will be performed by PGY-3 residents only. A 21 gauge needle will be used for the arthrocentesis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 31, 2019
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• All patients who require an arthrocentesis of a small and/or medium joint (defined previously)

Exclusion Criteria:

• Coagulopathic patients

• Patients on anticoagulants

• Patients with cellulitis overlying the joint.

• Patients with artificial joints

• Adults Unable to Consent

• Vulnerable Populations

Related Conditions & MeSH terms

• Effusion Joint

Intervention

Procedure:
• Arthrocentesis
Athrocentesis

Locations

Country	Name	City	State
United States	Lewis Katz School of Medicine at Temple University	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Temple University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Superiority of Method of arthrocentesis	Number of attempts until successful arthrocentesis	1 day
Secondary	Success of method	Completion of arthrocentesis after three attempts	1 day